Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge.
about
A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in MiceVaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.Viral vector-based influenza vaccines.New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.Long-term vaccine-induced heterologous protection against H5N1 influenza viruses in the ferret model.Immunobiology of influenza vaccinesExperimental vaccines against potentially pandemic and highly pathogenic avian influenza virusesBroad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumorsVirus-vectored influenza virus vaccines.Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma.Vesicular stomatitis virus-based H5N1 avian influenza vaccines induce potent cross-clade neutralizing antibodies in rhesus macaques.Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy.The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site.Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.Progress in filovirus vaccine development: evaluating the potential for clinical use.Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.Cross-protection of newly emerging HPAI H5 viruses by neutralizing human monoclonal antibodies: A viable alternative to oseltamivir.Long-term single-dose efficacy of a vesicular stomatitis virus-based Andes virus vaccine in Syrian hamsters.VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications.Signaling pathways in murine dendritic cells that regulate the response to vesicular stomatitis virus vectors that express flagellin.Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".Reverse Genetics of Rhabdoviruses
P2860
Q30370147-B53501DF-B21A-4DD0-B705-858EF9EE1339Q30375073-63765E51-AF85-47E8-B9C5-09FA72F98488Q30382576-13784E31-5278-4EC9-B1C6-CB491BA1A5EAQ30390938-EF0C33D4-307C-4DB7-94AB-047FC55C30ECQ30407424-3C808784-C907-4EEC-ABB9-545D3BDB4CB6Q30420397-85507AF8-BBC4-4682-9B9B-C56DE964A158Q30426771-430C89DD-F479-433B-B8AF-F74E9D26F006Q30427591-7316FA92-3753-4097-A5E8-13A05DBC4BA6Q33936327-8FEE8C86-CDFC-473B-9375-EB70CB248AF0Q34102268-A71CED8A-1FF6-4CE3-86ED-26ED03ECC0BCQ34198856-E8FAC6DD-7CC1-4754-80D5-2945C9493813Q35076920-6EA93D83-5995-4568-B21E-01287AEF2728Q35077419-27A2F69B-90A4-4D8A-81FA-FF98F07DA762Q35212733-DB539EF1-7F87-4EF8-86C2-BFE8F5DDCC22Q35531542-96DC4942-F467-4689-82AD-B21CC1B00051Q36100545-49F18981-2C55-468F-A916-8FC53A55296CQ36791009-83768ECA-C0A0-4B4B-A1F1-A45996998D31Q37141589-60EA4ABC-A2D7-40DC-8064-04E3E8D43224Q37611811-0304835E-42D8-4553-8E55-B93D81E16374Q37714030-9E72060E-6AB5-4FBB-A50E-6C34CE242AAAQ41820076-EF52EC47-4BB5-4839-8240-619FCC052576Q54378300-AB8EB31A-50F4-4A87-BA43-F11660B9E2AFQ57077874-4A35F453-8805-48FE-BC7A-206A5CCEFD3E
P2860
Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Potent vesicular stomatitis vi ...... gainst heterologous challenge.
@ast
Potent vesicular stomatitis vi ...... gainst heterologous challenge.
@en
type
label
Potent vesicular stomatitis vi ...... gainst heterologous challenge.
@ast
Potent vesicular stomatitis vi ...... gainst heterologous challenge.
@en
prefLabel
Potent vesicular stomatitis vi ...... gainst heterologous challenge.
@ast
Potent vesicular stomatitis vi ...... gainst heterologous challenge.
@en
P2093
P2860
P50
P356
P1433
P1476
Potent vesicular stomatitis vi ...... gainst heterologous challenge.
@en
P2093
Alex Silaghi
Amorsolo L Suguitan
John K Rose
Linda Buonocore
P2860
P304
P356
10.1128/JVI.02637-09
P577
2010-02-24T00:00:00Z